Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Immunotherapy has the power to become a cure for all cancers—already working to successfully treat some previously incurable cancers.
Immunotherapy promises to change the lives of all people affected by cancer. Get to know the unique benefits of cancer immunotherapy below.
Cancer immunotherapy—treatments that harness and enhance the innate powers of the immune system to fight cancer—represents the most promising new cancer treatment approach since the devevlopment of the first chemotherapies in the 1940s.
For more than 60 years, the Cancer Research Institute (CRI) has been the pioneer in advancing this new class of treatment.
Learn About CRI's Impact
Immunotherapy enables the immune system to recognize and target cancer cells, making it a universal answer to cancer.
Immunotherapy has been an effective treatment for patients with certain types of cancer that have been resistant to chemotherapy and radiation treatment (e.g., melanoma)
Immunotherapy can “train” the immune system to remember cancer cells. This “immunomemory” may result in longer-lasting remissions
Clinical studies on long-term overall survival have shown that the beneficial responses to cancer immunotherapy treatment are durable—that is, they can be maintained even after treatment is completed
Immunotherapy treatment harnesses the body's natural strength to fight cancer—empowering the immune system to conquer more types of cancer and save more lives.
See How Your Immune System Works
As a science-first organization dedicated to supporting cancer immunotherapy research, we're funding a future that fights back against cancer—all with your help.
Support our mission to cure ALL cancers, for good.
Join Team CRI by supporting our many dedicated fundraisers.
Create a profile and fill out a questionnaire to identify immunotherapy clinical trials you may be eligible for.
CALLING HOURS | M-F 8:30 a.m. to 6 p.m. ET
Se habla espanol
Request a call from a Clinical Trial Navigator
National Headquarters | One Exchange Plaza
55 Broadway, Suite 1802 | New York, NY 10006
(800) 992-2623(212) 832-9376Staff Directory
Atezolizumab’s third approval in the last year provides an important treatment option for a neglected population of patients with bladder cancer
TIME magazine honors Dr. Allison’s development of the first checkpoint immunotherapy, which has led to a revolution in cancer treatment.